Sympathetic Activation is Associated with Exercise Limitation in COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 13, Issue 5, 2016, Pages 589-594

  Haarmann, Helge ^a   Folle, Jan ^a   Nguyen, Xuan Phuc ^b   Herrmann, Peter ^a   Heusser, Karsten ^c   Hasenfuß, Gerd ^a   Andreas, Stefan ^a,d   Raupach, Tobias ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Specialist Lung Clinic Immenhausen   (Germany)

Author keywords

chronic obstructive pulmonary disease; ergospirometry; exercise limitation; handgrip exercise; sympathetic nerve activity

Indexed keywords

CARBON DIOXIDE; NEUROHORMONE; OXYGEN;

AGED; ARTICLE; BLOOD PRESSURE; BREATHING RATE; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEMALE; HAND GRIP; HEART RATE; HORMONE ACTION; HUMAN; MALE; MUSCLE SYMPATHETIC NERVE ACTIVITY; OXYGEN CONSUMPTION; OXYGEN SATURATION; PRIORITY JOURNAL; REST; ADRENERGIC SYSTEM; BLOOD; CASE CONTROL STUDY; EXERCISE TOLERANCE; INNERVATION; MIDDLE AGED; PARTIAL PRESSURE; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

AGED; BLOOD PRESSURE; CARBON DIOXIDE; CASE-CONTROL STUDIES; EXERCISE; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXYGEN; OXYGEN CONSUMPTION; PARTIAL PRESSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY RATE; REST; SYMPATHETIC NERVOUS SYSTEM;

EID: 84958061417     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1136272     Document Type: Article

References (35)

1. M.Decramer, W.Janssens, M.Miravitlles. Chronic obstructive pulmonary disease. Lancet 2012; 379:1341–1351.
2. B.R.Celli, C.G.Cote, J.M.Marin, C.Casanova, M.Montes de Oca, R.A.Mendez, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005–1012.
3. P.P.Walker, A.Burnett, P.W.Flavahan, P.M.Calverley. Lower limb activity and its determinants in COPD. Thorax 2008; 63:683–689.
4. M.B.Reid COPD as a muscle disease. Am J Respir Crit Care Med 2001; 164:1101–1102.
5. F.Laghi, M.J.Tobin. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003; 168:10–48.
6. K.Marquis, R.Debigare, Y.Lacasse, P.LeBlanc, J.Jobin, G.Carrier, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:809–813.
7. J.C.Hogg, F.Chu, S.Utokaparch, R.Woods, W.M.Elliott, L.Buzatu, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645–2653.
8. L.M.Fabbri, F.Luppi, B.Beghe, K.F.Rabe. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204–212.
9. P.J.Barnes, B.R.Celli. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165–1185.
10. C.Ashley, D.Burton, Y.B.Sverrisdottir, M.Sander, D.K.McKenzie, V.G.Macefield. Firing probability and mean firing rates of human muscle vasoconstrictor neurones are elevated during chronic asphyxia. J Physiol 2010; 588:701–712.
11. J.D.Maclay, W.MacNee. Cardiovascular disease in COPD:mechanisms. Chest 2013; 143:798–807.
12. S.Andreas, H.Haarmann, S.Klarner, G.Hasenfuss, T.Raupach. Increased sympathetic nerve activity in COPD is associated with morbidity and mortality. Lung 2014; 192:235–241.
13. S.Andreas, S.D.Anker, P.D.Scanlon, V.K.Somers. Neurohumoral activation as a link to systemic manifestation of chronic lung disease. Chest 2005; 128:3618–3624.
14. S.Heindl, M.Lehnert, C.P.Criée, H.GHasenfuß, S.Andreas. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001; 164:597–601.
15. T.Raupach, F.Bahr, P.Herrmann, L.Luethje, K.Heusser, G.Hasenfuss, et al. Slow breathing reduces sympathoexcitation in COPD. Eur Respir J 2008; 32:387–392.
16. L.M.Romer, M.I.Polkey. Exercise-induced respiratory muscle fatigue:implications for performance. J Appl Physiol 2008; 104:879–888.
17. C.A.Harms Insights into the role of the respiratory muscle metaboreflex. J Physiol 2007; 584:711.
18. W.D.Man, P.Kemp, J.Moxham, M.I.Polkey. Skeletal muscle dysfunction in COPD:clinical and laboratory observations. Clin Sci (Lond) 2009; 117:251–264.
19. P.Gagnon, J.S.Bussieres, F.Ribeiro, S.L.Gagnon, D.Saey, N.Gagne, et al. Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186:606–615.
20. M.F.Piepoli, A.J.Coats. The ‘skeletal muscle hypothesis in heart failure’ revised. Eur Heart J 2013; 34:486–488.
21. D.R.Seals, R.G.Victor. Regulation of muscle sympathetic nerve activity during exercise in humans. Exerc Sport Sci Rev 1991; 19:313–349.
22. R.L.Hammond, R.A.Augustyniak, N.F.Rossi, P.C.Churchill, K.Lapanowski, D.S.O'Leary. Heart failure alters the strength and mechanisms of the muscle metaboreflex. Am J Physiol Heart Circ Physiol 2000; 278:H818–828.
23. C.F.Notarius, D.J.Atchison, J.S.Floras. Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise. Am J Physiol Heart Circ Physiol 2001; 280:H969–976.
24. H.R.Middlekauff, J.Chiu, M.A.Hamilton, G.C.Fonarow, W.R.Maclellan, A.Hage, et al. Muscle mechanoreceptor sensitivity in heart failure. Am J Physiol Heart Circ Physiol 2004; 287:H1937–1943.
25. J.S.Floras Sympathetic nervous system activation in human heart failure:clinical implications of an updated model. J Am Coll Cardiol 2009; 54:375–385.
26. C.F.Notarius, S.Ando, G.A.Rongen, J.S.Floras. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. Eur Heart J 1999; 20:880–887.
27. H.R.Gosker, N.H.Lencer, F.M.Franssen, G.J.van der Vusse, E.F.Wouters, A.M.Schols. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003; 123:1416–1424.
28. A.B.Vallbo, K.E.Hagbarth, H.E.Torebjork, B.G.Wallin. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59:919–957.
29. B.G.Wallin, M.Esler, P.Dorward, G.Eisenhofer, C.Ferrier, R.Westerman, et al. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol Lond 1992; 453:45–58.
30. G.D.Thomas, S.S.Segal. Neural control of muscle blood flow during exercise. J Appl Physiol (1985) 2004; 97:731–738.
31. J.K.Shoemaker, P.Pandey, M.D.Herr, D.H.Silber, Q.X.Yang, M.B.Smith, et al. Augmented sympathetic tone alters muscle metabolism with exercise:lack of evidence for functional sympatholysis. J Appl Physiol (1985) 1997; 82:1932–1938.
32. C.C.Lang, G.H.Rayos, D.B.Chomsky, A.J.Wood, J.R.Wilson. Effect of sympathoinhibition on exercise performance in patients with heart failure. Circulation 1997; 96:238–245.
33. R.J.Butland, J.A.Pang, D.M.Geddes. Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema. J Appl Physiol Respir Environ Exerc Physiol 1983, 54:1368–1373.
34. C.L.Chang, G.D.Mills, J.D.McLachlan, N.C.Karalus, R.J.Hancox. Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease:effects on bronchodilator response and exercise. Intern Med J 2010, 40:193–200.
35. R.G.Victor, S.L.Pryor, N.H.Secher, J.H.Mitchell. Effects of partial neuromuscular blockade on sympathetic nerve responses to static exercise in humans. Circ Res 1989, 65:468–476.